Related Experiment Video
Updated: Nov 15, 2025
In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
Published on: November 2, 2020
How to make a better T cell: in vivo CRISPR screens have some answers
Matteo Villa1, Michal A Stanczak1, Erika L Pearce2
1Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Abstract:
Understanding what regulates CD8+ T cell responses is key to effectively harnessing these cells in human disease. In this issue of Cell, Huang et al. and Chen et al. use in vivo CRISPR screens to discover novel regulators of CD8+ T cell immunity to engineer a more efficacious response against cancer and infections.
Insights
Researchers identified new ways to control CD8+ T cell immunity using in vivo CRISPR screens. This discovery aims to improve treatments for cancer and infections by enhancing T cell responses.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- CD8+ T cell responses are crucial for fighting infections and cancer.
- Identifying regulators of CD8+ T cell immunity is essential for developing new therapies.
Purpose of the Study:
- To discover novel regulators of CD8+ T cell immunity.
- To engineer more effective CD8+ T cell-based therapies for cancer and infections.
Main Methods:
- Utilized in vivo CRISPR screens.
- Conducted large-scale genetic screens in a living organism.
Main Results:
- Identified previously unknown factors that modulate CD8+ T cell activity.
- Demonstrated the potential of these regulators to enhance anti-tumor and anti-viral immunity.
Conclusions:
- Novel regulators of CD8+ T cell immunity have been discovered.
- These findings pave the way for engineering improved T cell-based immunotherapies.
